cbdMD raises $1.7M gross via Series B Convertible Preferred, net $1.5M for working capital

cbdMD, Inc.

Issued 1,700,000 shares of Series B Convertible Preferred to four institutional investors for $1.7M gross proceeds.
Net proceeds of $1.5M after expenses; funds used for working capital.
Each share convertible into common at $1.00 per share, subject to anti-dilution and Alternative Conversion.
Series B Preferred accrues 10% annual dividends payable quarterly in shares or cash, senior liquidation preference.
Holders have no voting rights; beneficial ownership limited to 4.99% of common stock outstanding.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.99

cbdMD, Inc.: The Company filed a Certificate of Amendment to the Certificate of Incorporation designating 1,700,000 shares of authorized preferred stock as Series B Convertible Preferred Stock (effective 2025-09-29).

Change: charter amendment
Effective: 2025-09-29

Exact text from the filing

On September 29, 2025, the Company filed a Certificate of Amendment to the Certificate of Incorporation (the “Certificate of Designation”) designating 1,700,000 shares of the Company’s authorized preferred stock as Series B Convertible Preferred Stock, par value $0.001 per share.

View on SEC.gov

262 governance changes filed in the last 30 days. Browse all governance changes →

cbdMD, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-030537

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.